The U.S. Senate will investigate the price of Novo Nordisk's popular weight loss and diabetes drugs Ozempic and Wegovy.
The investigation into the Danish drugmaker was announced by Sen. Bernie Sanders, the Vermont Independent who chairs the Health, Education, Labor and Pensions Committee. Sanders also laid out in stark terms the dilemma facing American insurers, including the government, given how high the costs are for the potentially life changing drugs. "If the prices for these products are not substantially reduced they also have the potential to bankrupt Medicare, Medicaid, and our entire health care system," he wrote.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: